Investigating the Role of Microemboli in the Development of Cryptogenic Stroke

Oliver Danil^*
*Correspondence: Oliver Danil, Department of Anesthesiology and Critical Care, University of Pennsylvania Perelman, Philadelphia, USA, Email:

Introduction

Cryptogenic stroke, which accounts for a significant proportion of ischemic strokes, refers to cases in which the underlying cause of the stroke remains unidentified despite comprehensive diagnostic testing. These strokes are especially perplexing, as they affect individuals who may not exhibit traditional risk factors such as hypertension, diabetes, or atherosclerosis, leading to a sense of uncertainty and frustration for both clinicians and patients. Among the various mechanisms contributing to cryptogenic stroke, microemboli have emerged as a potential, yet often underrecognized, contributor.

Microemboli are small embolic particles, typically less than 100 micrometers in diameter, that can travel through the circulatory system and cause blockages in small blood vessels of the brain. These emboli may arise from a variety of sources, including the heart, arteries, or even venous thromboembolisms that traverse abnormal structures like a Patent Foramen Ovale (PFO). While much of the focus in cryptogenic stroke has traditionally been on larger emboli or identifiable risk factors, the role of microemboli is gaining increasing attention in recent years. This article explores the mechanisms through which microemboli may contribute to cryptogenic stroke, the challenges associated with their detection, and the potential implications for treatment and prevention strategies.

Description

Microemboli are tiny particles that are typically less than 100 micrometers in diameter and may be composed of various materials, including blood clots, fat, air bubbles, or atherosclerotic debris. These embolic particles can originate from different parts of the body, such as the heart, large arteries, or venous system, and travel through the bloodstream until they lodge in smaller blood vessels, leading to a blockage in the cerebral circulation.One of the most significant sources of microemboli is the heart, particularly in individuals with Atrial Fibrillation (AF), left atrial thrombus, or Patent Foramen Ovale (PFO). In atrial fibrillation, the irregular beating of the heart can cause the formation of blood clots in the left atrium, which can then be transported to the brain via the systemic circulation. The presence of a PFO can facilitate the passage of these clots from the right atrium to the left, bypassing the lungs' filtration system and allowing emboli to reach the brain.

Atherosclerotic plaque rupture in large arteries, particularly in the carotid or vertebral arteries, can result in the release of small embolic fragments that may travel distally to the smaller cerebral arteries. Additionally, arterial dissection, in which the inner lining of the artery tears, can release clot material that may embolize to the brain, potentially resulting in a microembolic event. In rare cases, microemboli can also originate from venous thromboembolism (e.g., deep vein thrombosis). When a clot forms in the deep veins, particularly in the legs, it can travel through the circulatory system, potentially passing through an abnormal connection like a PFO and reaching the brain. Microemboli can cause ischemic stroke by obstructing small arteries or arterioles within the brain. These vessels are crucial for supplying blood to the brain's microcirculation, and even the smallest blockage can lead to localized ischemia and brain injury. Unlike larger emboli that typically lodge in larger arteries, microemboli may cause more diffuse and subtle damage due to their tendency to affect smaller, distal cerebral vessels. This can lead to a condition known as "watershed infarction," where the regions of the brain that are at the border of two major arteries are deprived of adequate blood flow.

The presence of microemboli may result in multiple, scattered areas of ischemia, which are often not immediately detectable on traditional imaging techniques like CT or conventional MRI scans. Instead, these microemboli may cause transient ischemic attacks (TIAs) or even subtle cognitive changes that are easily overlooked, making the diagnosis of cryptogenic stroke challenging. One of the significant challenges in understanding the role of microemboli in cryptogenic stroke is their detection. Traditional diagnostic methods, such as CT or conventional MRI, are not always sensitive enough to identify the presence of microemboli, especially when they cause small, localized ischemic lesions. However, there are emerging diagnostic techniques that have improved the detection of microembolic events, including:

TCD is a non-invasive method that allows for the real-time detection of embolic signals in the cerebral circulation. The technique can be used to identify microembolic signals as they travel through the brainâ??s arteries. It is particularly useful in detecting microemboli in patients with PFO or other embolic sources. High-resolution MRI, including diffusion-weighted imaging (DWI), can sometimes detect microembolic lesions that are not visible on standard scans. Additionally, MRI can detect areas of ischemia that may be indicative of prior microembolic events. This technique, commonly used to identify PFOs, involves the injection of microbubbles into the bloodstream, which can pass through a PFO and enter the cerebral circulation. By tracking these bubbles, clinicians can identify the presence of paradoxical embolism and microemboli in the brain.

Microemboli have been implicated as a significant cause of cryptogenic stroke, particularly in individuals who do not have classic risk factors like hypertension or atherosclerosis. In these patients, the presence of microembolic events may be the underlying cause of ischemic stroke, despite the absence of a clear embolic source. Research has shown that microembolic signals are more frequently detected in cryptogenic stroke patients than in healthy controls, suggesting a strong association between microembolic activity and stroke occurrence. The relationship between microemboli and cryptogenic stroke is particularly evident in patients with PFO, atrial fibrillation, and arterial dissections, where these small emboli are able to bypass traditional filtration systems and enter the brain, causing ischemic events. In some cases, the detection of microembolic signals using advanced imaging techniques like TCD or MRI may help identify the embolic source, potentially leading to better-targeted treatments and improved patient outcomes [1-5].

Conclusion

The role of microemboli in cryptogenic stroke is an area of growing interest in the field of neurovascular research. Although these small embolic particles have long been suspected to contribute to ischemic events, their precise role in cryptogenic stroke is still not fully understood. The ability of microemboli to travel from various sources, including the heart, arteries, and venous system, and lodge in small brain vessels highlights their potential as a hidden cause of stroke in individuals without traditional risk factors. Advances in imaging techniques, such as transcranial Doppler ultrasound, MRI, and bubble contrast echocardiography, have provided new avenues for detecting microembolic events and clarifying their role in stroke pathogenesis. As the understanding of microemboli continues to evolve, it is likely that more targeted therapies and diagnostic protocols will emerge to address this elusive cause of cryptogenic stroke. Further research is needed to fully elucidate the mechanisms behind microemboli formation, their precise relationship with cryptogenic stroke, and the best approaches for detection and treatment. For patients who experience cryptogenic strokes, identifying microemboli as a potential source could lead to better individualized treatment strategies, reduced stroke recurrence, and improved long-term outcomes.

Acknowledgment

None.

Conflict of Interest

None.

References

1. Arsava, E. Murat, Johanna Helenius, Ross Avery and Mine H. Sorgun, et al. "Assessment of the predictive validity of etiologic stroke classification." JAMA Neurology 74 (2017): 419-426.

Google Scholar        Cross Ref                Indexed at

2. Grau, Armin J., Christian Weimar, Florian Buggle and Alexander Heinrich, et al. "Risk factors, outcome, and treatment in subtypes of ischemic stroke: The German stroke data bank." Stroke 32 (2001): 2559-2566.

Google Scholar        Cross Ref                Indexed at

3. Bang, Oh Young, Phil Hyu Lee, Sung Yeol Joo and Jin Soo Lee, et al. "Frequency and mechanisms of stroke recurrence after cryptogenic stroke." Ann Neurol 54 (2003): 227-234.

Google Scholar        Cross Ref                Indexed at

4. Ntaios, George, Vasileios Papavasileiou, Haralampos Milionis and Konstantinos Makaritsis, et al. "Embolic strokes of undetermined source in the Athens stroke registry: An outcome analysis." Stroke 46 (2015): 2087-2093.

Google Scholar        Cross Ref                Indexed at

5. Prabhakaran, Shyam, Steven R. Messé, Dawn Kleindorfer and Eric E. Smith, et al. "Cryptogenic stroke: Contemporary trends, treatments and outcomes in the United States." Neurol Clin Pract 10 (2020): 396-405.

Google Scholar        Cross Ref                Indexed at